被低估的PPA-ALS:一种具有强遗传性的独特临床病理亚型
在澳大利亚130例原发性非流利变异型PPA或语义变异型PPA患者中评估ALS发生率和家族史,并对28%的尸检病例进行神经病理检查。结果显示nfvPPA中ALS占18%、svPPA中占5%,PPA-ALS具有强家族史,且与FTLD-TDP病理显著相关。
要点
- nfvPPA患者中ALS发生率为18%,svPPA为5%,总体PPA-ALS占12%。
- PPA-ALS而非单纯PPA与神经退行性疾病强家族史相关。
- 所有nfvPPA-ALS和svPPA-ALS尸检病例均显示FTLD-TDP病理。
核心结论
- 在大规模nfvPPA和svPPA队列中ALS占12%,与FTD总体中报告的10%-15%相当,提示三分之一FTD-ALS患者以语言障碍为主要表现。
- PPA-ALS是唯一报告了完美临床病理关联的PPA表型,应重视在PPA中评估ALS。
研究设计与样本
- 研究纳入130例原发性非流利变异型PPA(nfvPPA)或语义变异型PPA(svPPA)患者,评估是否合并ALS及神经退行性疾病强家族史(Goldman评分≤3)。
- 对28%(n=36)的PPA及PPA-ALS病例进行了尸检神经病理检查。
主要发现
- ALS在nfvPPA患者中占18%,在svPPA患者中占5%。
- PPA-ALS而非单纯PPA患者具有强家族史。
- 尸检显示FTLD-TDP病理在nfvPPA-ALS中占100%、svPPA-ALS中占100%、nfvPPA中占24%、svPPA中占78%。
- 强家族史与潜在FTLD-TDP病理显著相关。
- 已知FTD/ALS基因的致病突变在家族性PPA病例中占100%,但在家族性PPA-ALS病例中仅占50%,提示该表型可能涉及新遗传变异。
关键数值与推荐
- ALS在nfvPPA中占18%,在svPPA中占5%,总体PPA-ALS占12%。
- FTLD-TDP病理在nfvPPA-ALS中占100%,在svPPA-ALS中占100%,在nfvPPA中占24%,在svPPA中占78%。
- 已知FTD/ALS基因致病突变在家族性PPA中占100%,在家族性PPA-ALS中占50%。
临床怎么用
- 对nfvPPA和svPPA患者应常规评估是否合并ALS。
- PPA患者出现ALS体征时提示强家族史和FTLD-TDP病理可能。
- 家族性PPA-ALS患者需考虑未知遗传变异,可转介遗传咨询。
局限性
- 仅28%(n=36)的PPA及PPA-ALS病例接受了尸检神经病理检查。
- 研究为澳大利亚单队列,遗传发现需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the incidence, heritability, and neuropathology of primary progressive aphasia (PPA) with amyotrophic lateral sclerosis (ALS) in a large Australian cohort. METHODS: A total of 130 patients with a primary nonfluent variant of PPA (nfvPPA) or semantic variant of PPA (svPPA) were assessed for concomitant ALS and a strong family history of neurodegenerative diseases (Goldman score ≤3). Neuropathologic examination was carried out in 28% (n = 36) of these PPA and PPA-ALS cases that had come to autopsy. RESULTS: ALS was identified in 18% of patients with nfvPPA and 5% of patients with svPPA. PPA-ALS but not PPA was found to have a strong family history. At autopsy, frontotemporal lobar degeneration (FTLD)-TDP was identified in 100% of nfvPPA-ALS cases, 100% of svPPA-ALS cases, 24% of nfvPPA cases, and 78% of svPPA cases. Clinicopathologic assessments revealed a significant association between a strong family history and underlying FTLD-TDP pathology. Pathogenic mutations in known frontotemporal dementia (FTD)/ALS genes were identified in 100% of these familial PPA cases but only 50% of familial PPA-ALS cases, suggesting the involvement of novel genetic variants in this underacknowledged phenotype. CONCLUSION: The present study identified ALS in 12% of a large cohort of patients with nfvPPA and svPPA, which is comparable to the 10%-15% reported in FTD overall, indicating that a third of patients with FTD-ALS will have a predominant language profile. These findings highlight the importance of assessing for ALS in PPA, particularly since this is the only PPA phenotype in which a perfect clinicopathologic association has been reported in to date.
引用
- Tan RH, Guennewig B, Dobson-Stone C, et al. The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability. Neurology. 2019. PMID: 30770429. doi:10.1212/WNL.0000000000007146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。